“…Since RCC is a highly vascular tumor, bleeding is one of the major complications seen after percutaneous ablation [16]. Nonetheless, the vascularity of RCC could potentially provide an intriguing target for adjunctive therapy as several reports in the literature describe trans-arterial embolization (TAE) of RCC prior to percutaneous ablation as a means to improve tumor localization, increase tumor ischemia, and decrease post-procedural bleeding [17,18,19,20,21,22,23,24]. Therefore, the purpose of this manuscript is to provide practitioners a guide to the technical aspects of these procedures, discuss our institutional outcomes, and provide a brief review of the literature so that they may best determine which patients could benefit from this treatment approach.…”